The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 24)
20 Stocks Moving in Friday’s Pre-Market Session
Gainers
Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) rose 83.4% to $16.34 in pre-market trading after the company reported a sharp rise in Q1 earnings and sales.
7 Stocks Moving In Thursday’s After-Hours Session
Gainers
Mirati Therapeutics (NASDAQ: MRTX) shares are trading higher after the company announced it received Breakthrough Therapy Designation from the FDA for patients with advanced non-small cell lung cancer harboring the KRAS G12C mutation.
Theravance Biopharma Stock Drops After Nezulcitinib Disappoints In COVID-19 Study
Theravance Biopharma Inc (NASDAQ:TBPH) has announced top-line results from its Phase 2 study evaluating nezulcitinib for hospitalized patients with confirmed COVID-19…
21 Stocks Moving in Monday’s Pre-Market Session
Gainers
Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V
Earnings Scheduled For May 4, 2021
Companies Reporting Before The Bell
• Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million.
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.